Skip to main content

Table 1 Number of samples in each dataset of the studied diseases (myelodysplastic syndrome MDS, Alzheimer's disease AD and colorectal cancer CRC) divided in stages and ordered according to the progression of each disease

From: Identification of expression patterns in the progression of disease stages by integration of transcriptomic data

  Disease subtypes and number of patient samples
Myelodysplastic Synd. (MDS) Control RCUD RCMD RAEB1 RAEB2 AML
 Patient samples (N) 11 6 17 4 5 10
Alzheimer’s disease (AD) Control Incipient Moderate Severe   
 Patient samples (N) 8 7 8 7   
Colorectal cancer (CRC) Control Stage 1 Stage 2 Stage 3 Stage 4  
 Patient samples (N) 25 13 37 34 20  
  1. MDS dataset includes 53 samples in 6 stages. AD dataset includes 30 samples and 4 stages. CRC dataset includes 129 samples and 5 stages. The controls correspond in all cases to samples of individuals without the disease. The stages are placed according to the progression of the diseases from the controls (no-disease) to the more acute or severe pathological states